HMGA1 — The Chromatin Architect of Fat Distribution
HMGA1 (High Mobility Group AT-Hook 1) encodes a non-histone chromosomal
protein that functions as a transcriptional regulator11 transcriptional regulator
HMGA1 binds to
A/T-rich regions of DNA and remodels chromatin structure, enabling other
transcription factors to access their target genes. It acts as an
architectural transcription factor — rather than directly activating genes,
it reshapes the DNA landscape to allow or prevent other regulators from
doing their work. The rs1776897 variant sits in an intergenic region near
HMGA1 on chromosome 6 and influences where your body preferentially
stores fat.
The Mechanism
HMGA1 plays a documented role in insulin signaling and glucose metabolism.
Mouse studies22 Mouse studies
HMGA1-deficient mice develop obesity, glucose intolerance,
and insulin resistance, demonstrating a causal role for this gene in
metabolic regulation have shown that HMGA1 deficiency leads to
obesity, glucose intolerance, and insulin resistance. The protein
regulates the expression of the insulin receptor itself, and reduced
HMGA1 function leads to decreased insulin receptor expression on cell
surfaces.
The rs1776897 G allele is associated with altered HMGA1 regulatory
activity in adipose tissue, promoting central (abdominal) fat deposition
rather than peripheral storage. This variant shows marked
sexual dimorphism33 sexual dimorphism
The effect on WHR is substantially stronger in women
than in men, a pattern shared by many fat distribution
loci, with stronger
effects in women.
The Evidence
The Shungin et al. 2015 meta-analysis44 Shungin et al. 2015 meta-analysis
Shungin et al. New genetic loci
link adipose and insulin biology to body fat distribution. Nature,
2015 identified the HMGA1
locus among 49 genome-wide significant loci for waist-to-hip ratio
adjusted for BMI (WHRadjBMI) across 224,459 individuals. HMGA1 was
specifically highlighted as one of the transcriptional regulators at
WHRadjBMI loci, and the signal showed stronger effects in women.
A Mendelian randomization study55 Mendelian randomization study
Emdin et al. Genetic association of
waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and
coronary heart disease. JAMA,
2017 demonstrated that
WHR-raising variants, including the HMGA1 locus, are causally linked to
increased risk of type 2 diabetes (OR 1.77 per 1-SD increase in WHR)
and coronary heart disease (OR 1.46). This moves the evidence beyond
mere association — the fat distribution pattern itself drives metabolic
disease.
The largest body fat distribution GWAS to date66 largest body fat distribution GWAS to date
Pulit et al.
Meta-analysis of genome-wide association studies for body fat
distribution in 694,649 individuals of European ancestry. Hum Mol
Genet, 2019 confirmed
the HMGA1 locus among replicated fat distribution signals across
nearly 700,000 individuals.
Practical Actions
The HMGA1 variant's effect on central fat deposition means that waist-to-hip ratio is a more meaningful health metric than BMI or total weight for carriers of the G allele. Central adiposity, even without overall obesity, carries metabolic risk. Monitoring insulin sensitivity markers and focusing on reducing visceral fat specifically are appropriate responses.
Interactions
HMGA1 sits within a broader network of fat distribution loci. The Shungin et al. 2015 pathway analysis implicated adipogenesis, angiogenesis, transcriptional regulation, and insulin resistance as interconnected processes. Carriers of WHR-raising alleles at multiple loci (including TFAP2B rs987237 and VEGFA rs6905288) may have compounded central adiposity risk, though formal gene-gene interaction studies are limited for these specific combinations.